HK Stock MarketDetailed Quotes

CIRC (01763)

Watchlist
  • 19.260
  • +0.200+1.05%
Trading Apr 15 10:03 CST
6.16BMarket Cap17.00P/E (TTM)

CIRC (01763) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
Drugs4.02B55.93%
Other business1.58B21.94%
Radioactive source product804.69M11.20%
放射治疗装备及相关服务601.33M8.37%
Irradiation184.66M2.57%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
核药销售4.02B55.93%
Medical device sales1.06B14.72%
放射源产品销售732.24M10.19%
Technical services599.37M8.34%
Other337.21M4.69%
核医疗装备销售230.63M3.21%
Irradiation service173.47M2.41%
Construction contract income37.08M0.52%
View all

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China7.19B100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More